Provided by Tiger Trade Technology Pte. Ltd.

JACOBIO-B

6.260
+0.1602.62%
Volume:942.40K
Turnover:5.91M
Market Cap:4.93B
PE:-31.15
High:6.360
Open:6.170
Low:6.100
Close:6.100
52wk High:11.800
52wk Low:1.430
Shares:787.00M
HK Float Shares:787.00M
Volume Ratio:0.31
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.201
ROE:-5.15%
ROA:-3.71%
PB:5.02
PE(LYR):-31.15
PS:21.60

Loading ...

JACOBIO-B Shares Surge Over 6% in Afternoon Trading as Global Development of JAB-23E73 Accelerates

Stock News
·
Feb 06

Jacobio Pharmaceuticals (01167) Announces Monthly Securities Return for January 2026

Bulletin Express
·
Feb 05

One Jacobio Pharmaceuticals Group Insider Raised Their Stake In The Previous Year

Simply Wall St.
·
Jan 25

Jacobio-B (01167) Spends HK$965,500 to Repurchase 150,000 Shares on January 2

Stock News
·
Jan 02

HK Stock Movement | JACOBIO-B (01167) Rises Nearly 5% After Securing Nearly $2B Deal with AstraZeneca, Says Upfront Payment Above Average

Stock News
·
Dec 24, 2025

Stock Track | JACOBIO-B Plummets 12.58% Intraday After Selling JAB-23E73 License to AstraZeneca

Stock Track
·
Dec 22, 2025

AstraZeneca Joins the Fray: The Battle Over Pan-KRAS Inhibitor Technology Begins to Shift

Stock News
·
Dec 22, 2025

China Shenhua (01088) Launches 100 Billion Yuan Asset Restructuring; COMEX Silver Hits Record High

Stock News
·
Dec 22, 2025

Jacobio Pharma Enters Global Exclusive License Agreement With AstraZeneca for Pan-Kras Inhibitor Jab-23E73

THOMSON REUTERS
·
Dec 21, 2025

JACOBIO-B (01167) Subsidiary Enters Licensing Agreement with AstraZeneca to Develop and Commercialize Pan-KRAS Inhibitor JAB-23E73

Stock News
·
Dec 21, 2025

Jacobio Pharmaceuticals Partners with AstraZeneca on Pan-KRAS Inhibitor JAB-23E73

Reuters
·
Dec 21, 2025

HK Movers | Biomedical Stocks Jump With Xuanzhu Biopharmaceutical up 22%

Tiger Newspress
·
Dec 12, 2025

HK Stock Movement | JACOBIO-B (01167) Surges Over 11% Again After Receiving RMB125M Initial Payment from Oceanpine Capital

Stock News
·
Dec 10, 2025

Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Simply Wall St.
·
Dec 08, 2025

HK Stock Movement | JACOBIO-B (01167) Surges Over 6% Intraday as Subsidiary Receives RMB125M Upfront Payment and Combination Therapy Published in The Lancet

Stock News
·
Dec 04, 2025

Jacobio (01167) Announces November 2025 Share Repurchase Data

Bulletin Express
·
Dec 03, 2025

Jacobio Pharmaceuticals Unit Receives Upfront Payment From Oceanpine Capital; Shares Lose 3%

MT Newswires Live
·
Dec 03, 2025

JACOBIO-B (01167) Receives First Payment Under Capital Increase and Equity Transfer Agreements

Stock News
·
Dec 02, 2025

Jacobio Unveils Positive Clinical Data for KRAS G12C and SHP2 Inhibitor Combination in The Lancet Respiratory Medicine

Reuters
·
Dec 01, 2025

Jacobio (1167) Announces Positive Phase I/IIa Results for KRAS G12C + SHP2 Inhibitor Combination

Bulletin Express
·
Dec 01, 2025